Gastrointestinal Adverse effect with oral bisphophonate Survey
Not Applicable
- Conditions
- osteoporosis
- Registration Number
- JPRN-UMIN000008422
- Lead Sponsor
- Shimane University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient who has received bisphosphonates. However, after discontinuing these bisphosphonates for six months, it is possible to register. 2) Woman who are in pregnant or who hopes for pregnancy 3) Patient who has serious hepatopathy, renal damage, and cardiac disease 4) Patients judged as improper to participate for the clinical trial by physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective sympotom derived from QOL inquiries at 1 or 3 months after initiation of bisphosphonate therapy.
- Secondary Outcome Measures
Name Time Method